Company: ZLAB
Filing Date: 2025-04-18
Form Type: PRE 14A
Source: 0001628280-25-018384
Chunk: 8

Company: Zai Lab Ltd
Filing Date: 2025-04-18
Form: PRE 14A
Chunk 8
---
 Trustee of Princeton University (2008-June 2019), and Trustee of The California Institute of Technology (2004-2008)

• Ph.D. in Chemistry from Stanford University and an A.B. in Organic Chemistry from Princeton University

#### Richard Brian Gaynor, M.D.
Independent Director

| Age |     | Director Since |     | Board Committees                |     | Other Public Company Boards |
| 75  |     |           2021 |     | Research and Development, Chair |     | Alkermes plc (NASDAQ)       |

Dr. Gaynor is an experienced oncologist who brings to the Board of Directors deep expertise in research and development and significant experience as a senior business executive in the biopharmaceutical industry.

#### Key Experience and Qualifications
• President and Chief of Research and Development at BioNTech US Inc. (formerly Neon Therapeutics, Inc.) (May 2020-Present), after serving in this role at Neon Therapeutics from November 2016 to May 2020

<div align='center'>-3-</div>

• Member of the Board of Directors of Alkermes plc (September 2019-Present)

• Member of the Board of Directors of Infinity Pharmaceuticals, Inc. (March 2020-March 2024)

• Various senior clinical development and medical affairs roles at Eli Lilly and Company (2002-2016), including Senior Vice President of Clinical Development and Medical Affairs

• Professor at the UCLA School of Medicine (1982-1991) and service on the faculty at the University of Texas Southwestern Medical School (1991-2002), including as the Chief of Hematology-Oncology and Director of the Simmons Cancer Center

• Author of nearly 150 publications and participant on numerous advisory boards and committees, including currently serving as a Director for the Damon Runyon Cancer Research Foundation and on committees for the American Association of Cancer Research and other cancer organizations

• M.D. from the University of Texas Southwestern Medical School, where he served a residency in internal medicine; fellowship training in hematology-oncology at the UCLA School of Medicine

#### Nisa Bernice Wing-Yu Leung

#### Independent Director
| Age |     | Director Since |     | Board Committees                    |     | Other Public Company Boards                     |
| 54  |     |           2014 |     | Nominating and Corporate Governance |     | Hong Kong Exchanges and Clearing Limited (HKSE) |

Ms. Le